|
This is an index of reports of adverse events (side effects, adverse reactions, etc.) related to Kaletra (Lopinavir / Ritonavir). Click on the relevant link below to view a selection of reports according to the event's seriousness level and/or the nature of the side effect / adverse reaction. Or scroll down to view a sample of recent reports further on this page.
Our database includes reports from Jan 2007 to Dec 2007. The information is not vetted and should not be cosidered as verified clinical evidence.
All cases (587)
Cases resulting in a serious event (585)
Cases resulting in death (105)
Cases resulting in life threatening events (66)
Cases resulting in hospitalization (288)
Cases resulting in disability (46)
Cases resulting in other serious reactions (218)
Below is a sample of reports where side effects / adverse reactions may be related to Kaletra (Lopinavir / Ritonavir). For a complete list and/or a specific selection of reports, please use the links in the index above.
Adverse event in female receiving Kaletra (Lopinavir / Ritonavir)
Reported by a physician from United Kingdom on 2007-10-30
Patient: female, weighing 52.4 kg (115.3 pounds)
Adverse reactions / side effects: Skin Exfoliation, Drug Hypersensitivity, Drug Interaction, Pyrexia, Erythema, Myalgia, Mucosal Inflammation, Drug Toxicity, Arthralgia, Oedema, Neutropenia, Rash Maculo-Papular, Blister
Adverse event resulted in: life threatening event, hospitalization
Suspect drug(s):
Kaletra
Administration route: Oral
Indication: Prophylaxis Against HIV Infection
Start date: 2007-07-11
End date: 2007-07-28
Kaletra
Dosage: 400 mg/100 mg
Administration route: Oral
Other drugs received by patient possibly interacting with the suspect drug:
Docetaxel
Administration route: Oral
Indication: Drug Therapy
Other drugs received by patient: Lamivudine + Zidovudine; Cefatrizine Propylenglycolate Sulfate
Adverse event in male receiving Kaletra (Lopinavir / Ritonavir)
Reported by a individual with unspecified qualification from Chile on 2007-10-30
Patient: male, weighing 67.0 kg (147.4 pounds)
Adverse reactions / side effects: Abdominal Pain, Vomiting, Lymphadenopathy, Nausea, Pyrexia, Pallor, Neoplasm
Adverse event resulted in: death
Suspect drug(s):
Kaletra (Lopinavir / Ritonavir)
Other drugs received by patient: Zidovudine; Lamivudine
Adverse event in male receiving Kaletra (Lopinavir / Ritonavir)
Reported by a physician from Japan on 2007-10-29
Patient: male
Adverse reactions / side effects: Drug Eruption, White Blood Cell Count Decreased, Hepatic Function Abnormal, Hyperuricaemia, Hypercholesterolaemia, Cerebral Infarction, Gamma-Glutamyltransferase Increased, Abdominal Distension, Feeling Abnormal, Thrombocytopenia
Suspect drug(s):
Norvir
Administration route: Oral
Indication: HIV Infection
Start date: 2000-06-15
End date: 2001-03-07
Kaletra
Administration route: Oral
Indication: HIV Infection
Start date: 2001-05-10
End date: 2006-11-15
Kaletra
Administration route: Oral
Indication: HIV Infection
Start date: 2006-11-16
Didanosine
Administration route: Oral
Indication: HIV Infection
Start date: 1999-11-01
End date: 2001-03-07
Stavudine
Administration route: Oral
Indication: HIV Infection
Start date: 1999-11-01
End date: 2001-03-07
Stavudine
Start date: 2001-05-10
Nelfinavir
Administration route: Oral
Indication: HIV Infection
Start date: 1999-11-01
End date: 2000-06-14
Saquinavir
Administration route: Oral
Indication: HIV Infection
Start date: 2000-06-15
End date: 2001-03-07
Efavirenz
Administration route: Oral
Indication: HIV Infection
Start date: 2001-03-08
End date: 2001-03-18
Bactrim
Administration route: Oral
Indication: Antifungal Prophylaxis
Start date: 2001-03-08
Zidovudine
Administration route: Oral
Indication: HIV Infection
Start date: 2001-05-10
End date: 2001-05-16
Abacavir Sulfate
Administration route: Oral
Indication: HIV Infection
Start date: 2001-05-10
Nevirapine
Administration route: Oral
Indication: HIV Infection
Start date: 2001-05-10
Nevirapine
Administration route: Oral
Start date: 2002-05-24
Other drugs received by patient: Amlodipine Besylate; Enalapril Maleate; Pravastatin Sodium; Pravastatin Sodium
Adverse event in male receiving Kaletra (Lopinavir / Ritonavir)
Reported by a individual with unspecified qualification from United States on 2007-10-26
Patient: male, weighing 3.0 kg (6.6 pounds)
Adverse reactions / side effects: Congenital Anomaly
Suspect drug(s):
Kaletra
Indication: Drug Exposure During Pregnancy
Abacavir W / Lamivudine
Indication: Drug Exposure During Pregnancy
Lamivudine + Zidovudine
Indication: Drug Exposure During Pregnancy
Nelfinavir Mesilate
Indication: Drug Exposure During Pregnancy
Adverse event in male receiving Kaletra (Lopinavir / Ritonavir)
Reported by a individual with unspecified qualification from Chile on 2007-10-26
Patient: male, weighing 46.0 kg (101.2 pounds)
Adverse reactions / side effects: Respiratory Failure, Pyrexia, Cough
Adverse event resulted in: hospitalization
Suspect drug(s):
Kaletra (Lopinavir / Ritonavir)
Other drugs received by patient: Didanosine; Zidovudine
Adverse event in 53 year old male receiving Kaletra (Lopinavir / Ritonavir)
Reported by a consumer/non-health professional from United States on 2007-10-26
Patient: 53 year old male
Adverse reactions / side effects: Jaundice, Hepatitis B, Liver Disorder, Hepatitis Fulminant, Ascites
Adverse event resulted in: hospitalization
Suspect drug(s):
Efavirenz
Administration route: Oral
Indication: HIV Infection
Start date: 2005-10-03
End date: 2006-09-25
Videx EC
Administration route: Oral
Indication: HIV Infection
Start date: 2005-10-03
End date: 2006-09-25
Retrovir
Administration route: Oral
Indication: HIV Infection
Start date: 2005-10-03
End date: 2006-09-25
Kaletra
Dosage: 4tablet/daily started from 27-oct-2006
Administration route: Oral
Indication: HIV Infection
Start date: 2006-09-26
End date: 2006-09-28
Epzicom
Dosage: 1 dosage form= 1 tablet.
Administration route: Oral
Indication: HIV Infection
Start date: 2006-09-26
End date: 2006-09-28
Other drugs received by patient: Urso 250; Cinal S; Cellulase; Lipase; Lendormin; Ursodiol
Adverse event in 40 year old male receiving Kaletra (Lopinavir / Ritonavir)
Reported by a individual with unspecified qualification from United States on 2007-10-26
Patient: 40 year old male
Adverse reactions / side effects: Atrioventricular Block
Suspect drug(s):
Kaletra
Administration route: Oral
Indication: HIV Infection
End date: 2007-10-17
Kaletra
Administration route: Oral
Start date: 2007-10-17
Other drugs received by patient: Atazanavir Sulfate; Tenofovir; Emtricitabine; Gemfibrozil; Trazodone HCL; Atorvastatin; Fish OIL
Adverse event in female receiving Kaletra (Lopinavir / Ritonavir)
Reported by a individual with unspecified qualification from Austria on 2007-10-26
Patient: female, weighing 67.0 kg (147.4 pounds)
Adverse reactions / side effects: Abortion Spontaneous
Suspect drug(s):
Kaletra (Lopinavir / Ritonavir)
Other drugs received by patient: Viread; Lamivudine; Lamivudine + Zidovudine
Adverse event in male receiving Kaletra (Lopinavir / Ritonavir)
Reported by a individual with unspecified qualification from Austria on 2007-10-25
Patient: male, weighing 45.0 kg (99.0 pounds)
Adverse reactions / side effects: Bronchopneumonia, Diarrhoea, Atypical Mycobacterial Infection, Lipodystrophy Acquired, Treatment Noncompliance
Adverse event resulted in: death
Suspect drug(s):
Kaletra
Administration route: Oral
Indication: HIV Infection
Start date: 2004-10-21
End date: 2005-11-16
Kaletra
Indication: Treatment Failure
Other drugs received by patient: Lamivudine + Zidovudine; Bactrim DS; Folic Acid; Flunitrazepam
Adverse event in male receiving Kaletra (Lopinavir / Ritonavir)
Reported by a consumer/non-health professional from United Kingdom on 2007-10-25
Patient: male
Adverse reactions / side effects: Drug Exposure During Pregnancy, Trisomy 18, Congenital Gastric Anomaly, Ventricular Septal Defect, Oesophageal Atresia, Gastric Disorder
Suspect drug(s):
Lamivudine
Indication: Drug USE FOR Unknown Indication
Start date: 2006-03-27
Zidovudine
Indication: Drug USE FOR Unknown Indication
Start date: 2006-03-27
Kaletra
Indication: Drug USE FOR Unknown Indication
Start date: 2006-03-27
Adverse event in male receiving Kaletra (Lopinavir / Ritonavir)
Reported by a health professional (non-physician/pharmacist) from France on 2007-10-24
Patient: male, weighing 53.0 kg (116.6 pounds)
Adverse reactions / side effects: Hypophosphataemia, Vitamin D Deficiency, Bone Pain, Blood Parathyroid Hormone Increased
Adverse event resulted in: hospitalization
Suspect drug(s):
Kaletra
Administration route: Oral
Indication: HIV Infection
Start date: 2002-03-01
Tenofovir Disoproxil
Administration route: Oral
Indication: HIV Infection
Start date: 2002-03-01
Efavirenz
Administration route: Oral
Indication: HIV Infection
Start date: 2002-03-01
Hydroxychloroquine Sulfate
Administration route: Oral
Indication: HIV Infection
Other drugs received by patient: Ritonavir; Cetirizine HCL; Atenolol; Molsidomine; DL-Lysine Acetylsalicylate; Omeprazole
Adverse event in 24 year old male receiving Kaletra (Lopinavir / Ritonavir)
Reported by a individual with unspecified qualification from United States on 2007-10-24
Patient: 24 year old male
Adverse reactions / side effects: Abdominal Pain, Weight Decreased, Gastrointestinal Motility Disorder, Hepatomegaly, Vomiting, Nausea, Gastritis
Suspect drug(s):
Viread
Etibi
Zithromax
Reyataz
Videx
Lamivudine
Kaletra
Bactrim
Adverse event in male receiving Kaletra (Lopinavir / Ritonavir)
Reported by a individual with unspecified qualification from Chile on 2007-10-23
Patient: male, weighing 67.0 kg (147.4 pounds)
Adverse reactions / side effects: Abdominal Pain, Vomiting, Lymphadenopathy, Nausea, Pyrexia, Pallor, Neoplasm
Adverse event resulted in: death
Suspect drug(s):
Kaletra (Lopinavir / Ritonavir)
Other drugs received by patient: Zidovudine; Lamivudine
Adverse event in receiving Kaletra (Lopinavir / Ritonavir)
Reported by a consumer/non-health professional from United States on 2007-10-23
Patient:
Adverse reactions / side effects: Anaemia
Suspect drug(s):
Septra
Zidovudine
Dosage: 10 mg/ml, unk
Administration route: Oral
Indication: Prophylaxis Against HIV Infection
Lamivudine
Dosage: 10 mg/ml, unk
Administration route: Oral
Indication: Prophylaxis Against HIV Infection
Nevirapine
Dosage: 50 mg/ml, unk
Administration route: Oral
Indication: Prophylaxis Against HIV Infection
Combivir
Dosage: 150/300 mg
Indication: Prophylaxis Against HIV Infection
Lamivudine
Dosage: 150 mg, unk
Stavudine
Indication: Prophylaxis Against HIV Infection
Kaletra
Dosage: 50 mg/200 mg
Indication: Prophylaxis Against HIV Infection
Nevirapine
Dosage: 200 mg, unk
Nelfinavir Mesilate
Dosage: unk, unk
Indication: Prophylaxis Against HIV Infection
Adverse event in 71 year old male receiving Kaletra (Lopinavir / Ritonavir)
Reported by a health professional (non-physician/pharmacist) from France on 2007-10-22
Patient: 71 year old male, weighing 53.0 kg (116.6 pounds)
Adverse reactions / side effects: Neuropathy, Renal Tubular Disorder, Vitamin D Deficiency, Blood Parathyroid Hormone Increased
Suspect drug(s):
Sustiva
Start date: 2002-03-01
Zerit
Videx
Kaletra
Start date: 2002-03-01
Viread
Start date: 2002-03-01
Plaquenil
Other drugs received by patient: Virlix; Tenormin; Corvasal; Aspegic 325; Omeprazole
Adverse event in male receiving Kaletra (Lopinavir / Ritonavir)
Reported by a health professional (non-physician/pharmacist) from France on 2007-10-22
Patient: male, weighing 53.0 kg (116.6 pounds)
Adverse reactions / side effects: Hypophosphataemia, Vitamin D Deficiency, Bone Pain, Pain
Adverse event resulted in: hospitalization
Suspect drug(s):
Viread
Administration route: Oral
Indication: HIV Infection
Start date: 2002-03-01
Kaletra
Administration route: Oral
Indication: HIV Infection
Start date: 2002-03-01
Sustiva
Administration route: Oral
Indication: HIV Infection
Start date: 2002-03-01
Plaquenil
Other drugs received by patient: Virlix; Tenormin; Corvasal; Aspegic 325
Adverse event in 24 year old male receiving Kaletra (Lopinavir / Ritonavir)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-10-19
Patient: 24 year old male
Adverse reactions / side effects: Abdominal Pain, Weight Decreased, Hepatomegaly, Lymphadenopathy, Bacterial Infection, Gastritis, Ileus Paralytic
Suspect drug(s):
Reyataz
Administration route: Oral
Videx
Etibi
Lamivudine
Kaletra
Viread
Zithromax
Bactrim
Adverse event in male receiving Kaletra (Lopinavir / Ritonavir)
Reported by a physician from Japan on 2007-10-19
Patient: male
Adverse reactions / side effects: White Blood Cell Count Decreased, Hyperlipidaemia, Gastrointestinal Perforation, Colon Operation, Hyperamylasaemia, Liver Disorder
Adverse event resulted in: hospitalization, disablity
Suspect drug(s):
Kaletra (Lopinavir / Ritonavir)
Other drugs received by patient: Lamivudine; Stavudine; Ganciclovir; Azithromycin; Bactrim
Adverse event in 48 year old male receiving Kaletra (Lopinavir / Ritonavir)
Reported by a health professional (non-physician/pharmacist) from France on 2007-10-19
Patient: 48 year old male
Adverse reactions / side effects: Renal Failure Acute
Adverse event resulted in: hospitalization
Suspect drug(s):
Kaletra
Administration route: Oral
Indication: HIV Infection
Start date: 2006-02-01
End date: 2007-07-01
Emtricitabine W / Tenofovir Disoproxil
Administration route: Oral
Indication: HIV Infection
End date: 2007-07-01
Other drugs received by patient: Tenofovir
Adverse event in male receiving Kaletra (Lopinavir / Ritonavir)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-10-18
Patient: male, weighing 1.8 kg (4.0 pounds)
Adverse reactions / side effects: Trisomy 18, Congenital Gastric Anomaly, Oesophageal Atresia, Ventricular Septal Defect, Gastric Disorder
Suspect drug(s):
Kaletra
Dosage: six capsules daily
Indication: Drug Exposure During Pregnancy
Start date: 2006-03-27
Lamivudine + Zidovudine
Dosage: two tablets daily
Indication: Drug Exposure During Pregnancy
Start date: 2006-03-27
Adverse event in 24 year old male receiving Kaletra (Lopinavir / Ritonavir)
Reported by a health professional (non-physician/pharmacist) from United States on 2007-10-18
Patient: 24 year old male
Adverse reactions / side effects: Abdominal Pain, Weight Decreased, Hepatomegaly, Lymphadenopathy, Bacterial Infection, Gastritis, Ileus Paralytic
Suspect drug(s):
Zithromax
Dosage: daily dose:600mg-freq:frequency: qd
Etibi
Dosage: daily dose:800mg-freq:frequency: qd
Kaletra
Dosage: text:3 df-freq:frequency: bid
Reyataz
Dosage: daily dose:300mg-freq:frequency: qd
Administration route: Oral
Lamivudine
Dosage: daily dose:150mg-freq:frequency: bid
Viread
Dosage: daily dose:300mg-freq:frequency: qd
Bactrim
Dosage: text:1 df-freq:frequency: qd
Videx
Dosage: daily dose:250mg-freq:frequency: qd
Adverse event in 29 year old male receiving Kaletra (Lopinavir / Ritonavir)
Reported by a individual with unspecified qualification from Austria on 2007-10-18
Patient: 29 year old male, weighing 70.0 kg (154.0 pounds)
Adverse reactions / side effects: Pneumonia Bacterial, Treatment Noncompliance
Suspect drug(s):
Kaletra (Lopinavir / Ritonavir)
Other drugs received by patient: Lamivudine + Zidovudine; Abacavir Sulfate W / Lamivudine; Efavirenz; Substitol; Oxazepam
Adverse event in male receiving Kaletra (Lopinavir / Ritonavir)
Reported by a physician from Austria on 2007-10-18
Patient: male, weighing 70.0 kg (154.0 pounds)
Adverse reactions / side effects: Diarrhoea, Atypical Mycobacterial Infection, Salivary Hypersecretion
Suspect drug(s):
Kaletra (Lopinavir / Ritonavir)
Other drugs received by patient: Abacavir Sulfate; Lamivudine; Trizivir; Tenofovir Disoproxil Fumarate; Atovaquone; Nystatin; Phenprocoumon; Candesartan Cilexetil; Ritonavir; Atazanavir Sulfate; Clarithromycin; Ethambutol Dihydrochloride
Adverse event in receiving Kaletra (Lopinavir / Ritonavir)
Reported by a consumer/non-health professional from United States on 2007-10-18
Patient:
Adverse reactions / side effects: Weight Decreased, Abdominal Pain, Gastrointestinal Motility Disorder, Hepatomegaly, Vomiting, Nausea, Gastritis
Suspect drug(s):
Septra DS
Lamivudine
Ethambutol HCL
Dosage: 800 mg, qd
Azithromycin
Dosage: 600 mg, qd
Atazanavir Sulfate
Dosage: 300 mg, qd
Didanosine
Dosage: 250 mg, qd
Kaletra
Adverse event in male receiving Kaletra (Lopinavir / Ritonavir)
Reported by a physician from United States on 2007-10-17
Patient: male, weighing 2.6 kg (5.7 pounds)
Adverse reactions / side effects: Congenital Toxoplasmosis
Suspect drug(s):
Invirase
Indication: HIV Infection
Start date: 2002-05-23
Combivir
Indication: HIV Infection
Start date: 2002-02-12
Kaletra
Indication: HIV Infection
Start date: 2002-02-12
AZT
Indication: HIV Infection
Start date: 2002-06-10
End date: 2002-06-20
|
